Skip to main content

Soft drinks have been linked to obesity.

SHANNON STAPLETON/REUTERS

Multinational food, drink and alcohol companies are using strategies similar to those employed by the tobacco industry to undermine public-health policies, health experts say.

In an international analysis of involvement by so-called "unhealthy commodity" companies in health policy-making, researchers from Australia, Britain, Brazil and elsewhere said self-regulation is failing and it is time the industry was regulated more stringently from outside.

The researchers said that through the aggressive marketing of ultra-processed food and drinks, multinational companies are now major drivers of the world's growing epidemic of chronic diseases such as heart disease, cancer and diabetes.

Story continues below advertisement

Writing in The Lancet medical journal, the researchers cited industry documents they said revealed how companies seek to shape health legislation and avoid regulation.

This is done by "building financial and institutional relations" with health professionals, non-governmental organizations and health agencies, distorting research findings, and lobbying politicians to oppose health reforms, they said.

They cited analysis of published research that found systematic bias from industry funding: articles sponsored exclusively by food and drinks companies were between four and eight times more likely to have conclusions that favoured the companies than those not sponsored by them.

Responding to the study's criticisms, UNESDA, which represents the soft drink industry in Europe, said experts recognize that obesity has many causes including diet, lack of exercise, genetics and lack of nutritional knowledge.

It added that, within the EU, the European Commission had opted to take a "multi-stakeholder approach gathering governments, industry, the health-care community and civil society to work together to teach people how to … lead healthy, balanced lifestyles."

The researchers said, however, that their evidence shows this collaborative approach has failed. They recommended that firms should have no role in national policies on chronic diseases.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies